Ftse Mib
33.629,21
-0,32%
DAX
18.001,60
0,54%
S&P 500
5.127,79
1,26%
NASDAQ
16.156,33
1,99%
Bitcoin
63.221,86
-1,06%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Wave Life Sciences Ltd (WVE) Wave Life Sciences Ltd (WVE) Notizie

Wave Life Sciences Ltd

WVE
6,14
0,26 (4,42%)
04 Mag 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
02/5/202414:30GLOBEWave Life Sciences First Quarter 2024 Financial Results..
30/4/202414:30GLOBEWave Life Sciences Announces Approval of First Clinical..
23/4/202414:30GLOBEWave Life Sciences Announces Continued Momentum in GSK..
27/3/202413:30GLOBEWave Life Sciences to Present at Upcoming Investor..
06/3/202413:55EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
06/3/202413:39EDGAR2Form 8-K - Current report
06/3/202413:30GLOBEWave Life Sciences Reports Fourth Quarter and Full Year 2023..
28/2/202414:30GLOBEWave Life Sciences Fourth Quarter and Full Year 2023..
27/2/202414:30GLOBEWave Life Sciences Announces Upcoming Presentations at MDA..
12/2/202422:15EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
08/2/202401:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/2/202401:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/2/202401:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/2/202401:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/1/202414:11EDGAR2Form 8-K - Current report
08/1/202414:00GLOBEWave Life Sciences Highlights Recent Achievements and..
04/1/202422:07EDGAR2Form 8-K - Current report
03/1/202414:30GLOBEWave Life Sciences to Present at 42nd Annual J.P. Morgan..
15/12/202314:36EDGAR2Form 8-K - Current report
15/12/202314:30GLOBEWave Life Sciences Announces Initiation of Dosing in Phase 2..
08/12/202312:06EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
08/12/202303:26EDGAR2Form 8-K - Current report
07/12/202313:00GLOBEWave Life Sciences Prices $100 Million Public Offering of..
06/12/202322:13EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
06/12/202322:10GLOBEWave Life Sciences Announces Proposed Public Offering of..
06/12/202322:08GLOBEWave Life Sciences Announces Initiation of Dosing in..
22/11/202314:30GLOBEWave Life Sciences to Present at 6ᵗʰ Annual Evercore ISI..
09/11/202322:27EDGAR2Form 8-K - Current report
09/11/202314:52EDGAR2Form S-8 - Securities to be offered to employees in employee..
09/11/202314:52EDGAR2Form S-8 - Securities to be offered to employees in employee..
09/11/202313:55EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/11/202313:39EDGAR2Form 8-K - Current report
09/11/202313:30GLOBEWave Life Sciences Reports Third Quarter 2023 Financial..
03/11/202321:05GLOBEWave Life Sciences Third Quarter 2023 Financial Results..
02/10/202313:31EDGAR2Form 8-K - Current report
28/9/202322:15GLOBEWave Life Sciences Highlights Growth Strategy for Building..
25/9/202314:30GLOBEWave Life Sciences to Present at the Chardan 7th Annual..
06/9/202314:30GLOBEWave Life Sciences to Present at the H.C. Wainwright 25th..
05/9/202322:05EDGAR2Form 8-K - Current report
05/9/202313:30GLOBEWave Life Sciences Announces Submission of First Clinical..
24/8/202303:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/8/202322:55EDGAR2Form 144 - Report of proposed sale of securities
10/8/202302:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/8/202302:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/8/202302:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/8/202323:01EDGAR2Form 8-K - Current report
03/8/202313:56EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
03/8/202313:37EDGAR2Form 8-K - Current report
03/8/202313:30GLOBEWave Life Sciences Reports Second Quarter 2023 Financial..
27/7/202314:30GLOBEWave Life Sciences Second Quarter 2023 Financial Results..
Apertura: 5,93 Min: 5,90 Max: 6,3799
Chiusura: 5,88

La tua Cronologia

NASDAQ
WVE
Wave Life Sciences
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network